TetraLogic Pharmaceuticals' Series C - III Round

TetraLogic Pharmaceuticals raised a round of funding on May 24, 2011.

TetraLogic Pharmaceuticals is focused on the discovery and development of drugs to treat cancer through technology which allows drugs to be developed that unblock the cell death or apoptosis pathway, …

Articles about TetraLogic Pharmaceuticals' Series C - III Round: